Fermented Stevia Shows Promise in Targeting Pancreatic Cancer, New Research Reveals
Could a common sugar substitute, enhanced by the power of probiotics, offer a novel approach to fighting one of the deadliest cancers? Groundbreaking research from Hiroshima University suggests that fermenting stevia leaf extract with bacteria found on banana leaves dramatically increases it’s ability to kill pancreatic cancer cells while leaving healthy cells unharmed. This finding, published in the International Journal of Molecular sciences, offers a potentially significant step forward in the search for effective treatments against this aggressive disease.
Pancreatic cancer is a especially challenging malignancy. Globally, incidence and mortality rates are rising, and the five-year survival rate remains stubbornly low, hovering below 10%. Its aggressive nature, tendency to metastasize, and resistance to conventional treatments like surgery, radiation, and chemotherapy create an urgent need for innovative therapeutic strategies. For decades, researchers have been exploring natural compounds, particularly those derived from medicinal plants, as potential allies in the fight against cancer.
The Power of Fermentation: Unlocking Stevia’s Potential
Stevia leaf extract has previously shown hints of anticancer activity, but harnessing its full potential has proven difficult. The challenge lies in isolating and applying the specific bioactive components responsible for these effects. The Hiroshima University team, led by Professor Masanori Sugiyama and Associate Professor Narandalai Danshiitsoodol, took a novel approach: microbial biotransformation.
“To enhance the pharmacological efficacy of natural plant extracts, microbial biotransformation has emerged as an effective strategy,” explains Professor Sugiyama, whose lab has a long-standing history of isolating and evaluating the health benefits of over 1,300 lactic acid bacteria (LAB) strains sourced from diverse natural sources. “We hypothesized that fermenting stevia could structurally alter the extract,creating bioactive metabolites with enhanced anticancer properties.”
Their research focused on fermenting stevia leaf extract with Lactobacillus plantarum SN13T (FSLE), a strain isolated from banana leaves. the team then meticulously compared the effects of the fermented extract against non-fermented stevia extract on both pancreatic cancer cells (PANC-1) and healthy human embryonic kidney cells (HEK-293) in a laboratory setting.The results were striking.
“Our findings indicate that FSLE demonstrates significantly greater cytotoxicity – the ability to kill cells – than the non-fermented extract at equivalent concentrations,” states Professor Sugiyama.Crucially,FSLE exhibited lower toxicity towards the healthy kidney cells,even at the highest concentrations tested. This selective targeting is a critical factor in developing effective cancer therapies, minimizing harm to the patient.
Identifying the Key compound: Chlorogenic Acid Methyl Ester (CAME)
Further analysis pinpointed chlorogenic acid methyl ester (CAME) as the primary anti-cancer compound responsible for the observed effects. Interestingly, the fermentation process reduced the concentration of chlorogenic acid itself by six-fold. This wasn’t a loss, though, but a transformation.
“This microbial transformation was likely due to specific enzymes within the Lactobacillus plantarum SN13T strain,” explains Associate Professor Danshiitsoodol. “Our data demonstrate that CAME exhibits stronger toxicity to PANC-1 cells and promotes apoptosis – programmed cell death – compared to chlorogenic acid alone.” In essence, the fermentation process doesn’t just deliver more of the active compound; it creates a more potent version.
What’s Next? Moving Towards In-vivo Studies
While these laboratory results are highly promising, the researchers emphasize the need for further inquiry. The next step involves studying the effects of fermented stevia in a mouse model. This will allow them to assess the effectiveness of different dosages and understand how the treatment performs within a whole-body system.
“The present study has substantially enhanced our understanding of the mechanism of action of Lactobacillus plantarum SN13T in the fermentation of herbal extracts,” concludes Associate Professor Danshiitsoodol. “It also offers a valuable research perspective on the potential request of probiotics as natural anti-tumor agents.”
This research represents a compelling exmaple of how combining traditional knowledge of medicinal plants with cutting-edge probiotic science can unlock new possibilities in cancer prevention and therapy. While more research is needed,the findings offer a beacon of hope in the ongoing battle against pancreatic cancer.
Research Team:
Rentao Zhang and Masafumi Noda, Department of Probiotic Science for Preventive Medicine, Graduate School of Biomedical and Health Sciences, hiroshima university
Sayaka Yonezawa and Keishi Kanno, Department of General internal Medicine, Hiroshima University Hospital
Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with a qualified healthcare professional for any health concerns or before making any decisions related